Currently accepted at: JMIR mHealth and uHealth
Date Submitted: Jul 8, 2026
Date Accepted: Oct 2, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/105519
The final accepted version (not copyedited yet) is in this tab.
Suicidal Ideation Trajectories After Remote Patient Monitoring Alerts in Mood Disorders: A Retrospective Cohort Study
ABSTRACT
Background:
Measurement-based care improves depression outcomes, yet implementation remains uncommon. Digital remote patient monitoring (RPM) tools collecting patient-reported outcomes (PROs) with automated alerts are increasingly deployed, but the respective contributions of algorithmic detection and clinician response remain unclear.
Objective:
To describe real-world use of a CE-marked digital RPM device for mood disorders and characterize symptom trajectories around algorithmic alerts, distinguishing alerts overall from those followed by clinician response.
Methods:
Multicenter retrospective cohort study using post-market clinical follow-up data from October 31, 2025, to May 4, 2026, implying thirty-four French psychiatric centers using a Class IIa CE-marked RPM device. We included all consecutive adults (≥18 years) treated for major depressive episode or manic episode, who completed at least one weekly questionnaire and did not opt out of research use of their data. The questionnaires consisted in weekly electronic PROs collection (PHQ-9, suicidal ideation item, adapted GAD-2, medication adherence) with threshold-based alerts routed to clinical teams. Alerts were classified as followed or not by documented clinician response. Outcomes included engagement and operational metrics (completion rate, patient response time, alert processing time, response conversion rate) and exploratory pre/post-alert trajectories for suicidal ideation, anxiety, and depression, analyzed using segmented interrupted time-series regression with Newey-West correction at both the alert and response-bearing alert levels.
Results:
Among 111 patients (median [IQR] age, 41 [31-54] years; 76% female), 84% were treated for depressive disorders, and 16% for bipolar disorder. Overall, 92% of questionnaires were completed, with completion rates exceeding 80% through month 5. Median patient response time was 17 hours, median clinician response time after alerts was 50 hours, and 69% of alerts were followed by a documented response. Response-bearing alerts were associated with significant slope inflections for suicidal ideation (−0.007/day; P=0.01) and anxiety (−0.004 per day; P<0.001), with nonsignificant trend for depression. Across all alerts, no inflection was observed for suicidal ideation, whereas anxiety showed a significant inflection and depression a level shift without slope change.
Conclusions:
In this real-world cohort, symptom trajectory changes were most evident when alerts were followed by clinician response. These findings support further evaluation of closed-loop RPM in randomized trials. Clinical Trial: The study was conducted under the French Reference Methodology MR-004 of the Commission Nationale de l'Informatique et des Libertés (CNIL) (research not involving human subjects, in-house studies on health data).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.